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Cytokines control a variety of cellular responses
including proliferation, differentiation, survival and
functional activation, via binding to specific receptors
expressed on the surface of target cells [1]. The cytokine
receptors of the haemopoietin family are defined by the
presence of a conserved 200 amino acid extracellular
domain known as the haemopoietin domain [2]. We
report here the isolation of NR6, a haemopoietin receptor
that, like the p40 subunit of interleukin-12 (IL-12) [3] and
the EBI3 gene induced by Epstein–Barr virus infection in
lymphocytes [4], contains a typical haemopoietin domain
but lacks transmembrane and cytoplasmic domains.
Although in situ hybridisation revealed NR6 expression at
multiple sites in the developing embryo, mice lacking
NR6 did not display obvious abnormalities and were born
in the expected numbers. Neonatal NR6–/– mice failed to
suckle, however, and died within 24 hours of birth,
suggesting that NR6 is necessary for the recognition or
processing of pheromonal signals or for the mechanics of
suckling itself. In addition, NR6–/– mice had reduced
numbers of haemopoietic progenitor cells, suggesting a
potential role in the regulation of primitive haemopoiesis.
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Results and discussion
Using an oligonucleotide encoding the conserved WSXWS
(single-letter amino acid code) motif present in the extracel-
lular domains of hemopoietin receptors [2], a cDNA denoted
NR6 was isolated from murine testis, brain and KUSA cell
line [5] cDNA libraries. The majority of clones contained a
long open-reading frame (NR6.1) of 1275 nucleotides. The
predicted protein sequence was consistent with that of a
haemopoietin receptor [2]: a potential signal sequence and
immunoglobulin-like domain preceded a haemopoietin
domain (HD) containing the expected cysteine pairs and a
WSEWS motif, and sequence with loose homology to part
of the fibronectin type III repeat was evident at the car-
boxyl terminus. Independent clones were also isolated with
deduced open reading frames (NR6.2 and NR6.3) that con-
tained divergent sequences carboxy-terminal to the HD
(Figure 1). Human NR6 cDNAs, all of which were homo-
logues of murine NR6.1, were isolated using low-strin-
gency hybridisation of murine probes to foetal kidney,
foetal liver and placental libraries (Figure 1). No hydropho-
bic sequences typical of a transmembrane domain nor
motifs usually required for membrane association via lipid
attachment [6] were evident, indicating that NR6 is a
soluble member of the haemopoietin receptor family. The
primary amino-acid sequences of human and mouse NR6.1
were 98% identical and are identical to the recently
described cytokine-like factor-1 (CLF-1) [7]. Although
NR6 has sequence similarity to membrane-bound
haemopoietin receptors (Figure 1), structurally it appears to
be analogous to the two other exclusively soluble members
of the haemopoietin receptor family — EBI3, a 34 kDa gly-
coprotein secreted by B lymphocytes in response to EBV
[4], and the p40 component of IL-12 [3].
Embryos at 7.5–11.5 days post coitum (dpc) were examined
for NR6 expression by whole-mount in situ hybridisation
with digoxigenin-labelled riboprobes. NR6 expression was
first detected at 9.5 dpc in the first branchial arch, the fore-
limb bud and mesonephric duct (Figure 2a). At 10.5 and
11.5 dpc, intense expression was seen in nasal processes
and the maxillary and mandibular components of the first
branchial arch. Expression was also seen in the limbs, in the
mesenchyme overlying the otic vesicle and in the dermato-
myotome (Figure 2b). Expression of NR6 in 12.5, 14.5 and
18.5 dpc embryos was examined by in situ hybridisation of
radiolabelled probes to tissue sections. At each age, NR6
was expressed in the craniofacial mesenchyme and in
tissues derived from the first branchial arch. At 14.5 and
18.5 dpc, NR6 transcripts were also observed in dental
papillae, in the tongue and throughout the mesenchyme
beneath the oral and nasal epithelia (Figure 2e). Expres-
sion was observed in the secretory buds and ducts of the
submandibular salivary gland from 14.5 dpc and in the
lacrimal glands at 18.5 dpc (Figure 2e). At 12.5 and
14.5 dpc the ectoderm of Rathke’s pouch expressed NR6,
although transcripts were not detected in the pituitary
gland. NR6 was expressed in the mesonephric (Wolffian)
duct at 12.5 dpc and in the growing tips of the collecting
ducts of the kidney throughout embryogenesis (Figure 2c).
Expression was observed in the genital tubercle but was
not detected in other reproductive organs (Figure 2c). NR6
transcripts were detected in the lung buds at 12.5 dpc and
in the bronchi, but not in lung parenchyma, at 14.5 and
18.5 dpc (Figure 2c). From 12.5 dpc, NR6 expression was
observed in all precartilaginous membranous blastema. At
later times, expression was prominent in tissues adjacent to
forming cartilage, such as the intermediate digits of the
hindlimb (Figure 2c). NR6 transcripts were not detected in
the developing brain before 17.5 dpc. At this time, expres-
sion was observed in the nuclear zone of the neopallial
cortex and in the hippocampus (Figure 2c). Rare NR6-pos-
itive cells were also observed in the midbrain. By birth,
expression of NR6 in the brain was no longer detectable.
To examine the biological role of NR6 in vivo, a targeting
vector in which the NR6 immunoglobulin-like and
haemopoietin domains were replaced with a G418-resis-
tance cassette (Figure 3a) was used for homologous recom-
bination in embryonic stem (ES) cells to generate mice in
which the NR6 gene had been functionally deleted. A
number of mice in litters born of NR6+/– parents died within
24 hours of birth. Genotyping revealed that these mice were
homozygous for the targeted NR6 allele, whereas their
healthy littermates were heterozygotes or wild type
(Figure 3b). As anticipated, NR6 transcripts were detected
in northern blot analysis of RNA from NR6+/– or wild-type
mice, but were absent in samples from homozygous
mutants (Figure 3c). Although NR6–/– mice were born in
numbers expected from normal Mendelian segregation of
alleles, no NR6–/– mice survived beyond 24 hours after
birth. Thus loss of NR6 does not compromise embryonic
survival but is lethal during the first day of life.
Extensive histological comparison of serial sections from
neonatal NR6–/– mice and wild-type littermates revealed
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Figure 2
Expression of NR6 in the mouse embryo. (a,b) Whole-mount in situ
hybridisation of (a) 9.5 dpc and (b) 11.5 dpc embryos showing NR6
expression in the mesonephric duct (md), limb buds (lb), first branchial
arch (ba1), nasal processes and dermatomyotome (dm). (c) Sagittal
section of a 14.5 dpc embryo showing NR6 expression in lung (l),
kidney (k), genital tubercle (gt), precartilaginous condensations of the
digital metacarpals (d), intervertebral discs (id), tongue (t) and facial
mesenchyme. (d,e) Serial sagittal sections of the head from an
18.5 dpc embryo, hybridised with (d) sense and (e) antisense probes
revealing NR6 expression in the cortex (c) and hippocampus (hi), as
well as in facial mesenchyme, developing teeth (th) and salivary gland
(sg). Scale bars, 1 mm. Hybridisation of a 33P-labelled full-length NR6
cDNA probe to whole-mount (70°C) and embryonic paraffin sections
(50°C) were performed as described previously [12,13].
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NR6 is a member of the haemopoietin receptor family. Alignment of the
amino-acid sequence of murine (mNR6) and human (hNR6) NR6 with
those of human Epstein–Barr virus-induced protein (hEBI3), the p40
component of human IL-12 (hIL-12p40), and the human receptors for
IL-6 (hIL-6Rα), ciliary neurotrophic factor (hCNTFRα) and granulocyte-
macrophage colony-stimulating factor (hGMRα). Conserved residues
in the SD100A (grey) and SD100B (blue) regions of the haemopoietin
domain are shaded, with the characteristic cysteine pairs and
WSXWS motifs in bold. The carboxy-terminal sequences that diverge
in mNR6.1, mNR6.2 and mNR6.3 are shown in pink together with the
hNR6 carboxyl terminus. 
no gross structural abnormalities or histopathology. Spe-
cific staining of bone and cartilage in cleared embryos [8]
collected the day before birth also failed to detect any con-
sistent skeletal abnormalities (data not shown). Closer
examination soon after birth revealed that NR6–/– mice
failed to suckle effectively and had stomachs devoid of
milk (Figure 4). The NR6–/– mice had normal body
weights, a normal respiratory rate, were well oxygenated
and responded to touch with vocalisation, righting and
rooting reflexes. They could open and close their mouths
and dissections revealed that the palate, mouth and
oesophagus were intact. Suckling is thought to be initiated
by pheromonal responses which are processed by neural
networks involving the olfactory bulb, and ultimately, the
hippocampus [9]. Indeed, in mice lacking the Fyn tyro-
sine kinase, a failure to suckle has been correlated with
abnormalities at these sites [10]. In contrast, in mice
lacking the Brn-3a POU domain protein, neuronal loss in
the trigeminal ganglion accompanied a failure to suckle,
suggesting that sensory defects in the face or mouth may
also impair this response [11]. The brains of two newborn
NR6–/– mice and two wild-type littermates were serially
sectioned in the coronal plane and every fifth section was
photographed. Sagittal sections through the brain, face
and mouth of several animals were also examined. No
abnormalities were observed in the anatomy of the NR6–/–
brains, including the cortex and hippocampus, the two
sites of NR6 expression, and the olfactory bulb. The com-
plete brain stem was not examined. Similarly, gross struc-
tural or histological abnormalities of the face and mouth
were not evident. Thus, although our data establish that
NR6 is indispensable in the initiation and/or maintenance
of suckling in neonatal mice, and reveal NR6 expression
in facial and neural sites previously implicated in suckling,
we have not been able to identify the mechanism by
which its role is mediated. It seems likely, however, that
the expression of NR6 in facial tissues and/or the brain is
necessary for the recognition or processing of pheromonal
signals or for the mechanics of suckling itself.
We also examined whether haemopoiesis was perturbed in
NR6–/– mice. The haematocrit number of circulating
platelets and number and morphological distribution of
white blood cells were normal in NR6–/– mice. The
numbers and lineage commitment of haemopoietic progen-
itor cells in neonatal mice were enumerated in clonogenic
cultures. NR6–/– bone marrow and spleen contained
1.5–2.5-fold fewer progenitors capable of responding to the
combination of stem-cell factor (SCF), IL-3 and erythropoi-
etin (EPO). A similar reduction in the number of clono-
genic cells responsive to macrophage colony-stimulating
factor (M-CSF) or SCF alone was also observed (data not
shown). The deficiencies did not reflect a reduction in cells
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Figure 3
Gene targeting of the NR6 locus. (a) Structure of the murine NR6 gene
with exons boxed and coding region as filled boxes. The targeting
vector and the predicted structure of the targeted allele are shown.
(b) Southern blot of SpeI-digested genomic DNA from the tails of mice
from a cross between heterozygous (NR6+/–) parents. The endogenous
(9.9 kb) and mutant (7.1 kb) NR6 alleles were detected by the genomic
NR6 probe. (c) Northern blot analysis of RNA extracted from the lungs,
kidneys, heads and limbs of neonatal NR6–/–, wild-type (+/+) and
heterozygous (+/–) mice using full-length NR6 cDNA and control
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) probes.
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Figure 4
Failure to suckle in NR6–/– mice. A litter of living newborn mice from a
cross between NR6+/– parents, showing the empty stomachs of three
NR6–/– mice (left). Wild-type or NR6+/– mice, four of which are shown
at the right, suckle normally.
committed to any particular lineage; fewer colonies of all
types monitored were evident (Table 1). The numbers and
lineage commitment of haemopoietic progenitor cells were
normal in the livers of neonatal NR6–/– mice (Table 1), and
in similar analyses, no disturbances in foetal liver progenitor
numbers or lineage commitment were evident at day 13 of
gestation (data not shown). Although it is possible that the
debilitating effects of the failure to suckle in these mice
causes marrow and spleen progenitor cell numbers to
quickly decrease after birth, the intact response of liver
progenitors from the same animals suggests that this is not
the case. Rather, NR6 may be required for progenitor cell
production in spleen and bone marrow late in gestation. In
support of a potential role as a haemopoietic regulator, NR6
is expressed by a number of stromal cell lines known to
support haemopoiesis (data not shown). 
Thus, NR6 is indispensable for suckling, with lethal con-
sequences in neonatal mice lacking this protein. It is also
required for appropriate production of haemopoietic prog-
enitor cells in the bone marrow and spleen. Further
studies are required to define this soluble haemopoietin
receptor biochemically and to further explore its contribu-
tions to these complex biological processes.
Supplementary material
Additional methodological details are published with this paper on the internet.
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Table 1
Haemopoietic progenitor cell profile in neonatal NR6-deficient mice.
Organ NR6 genotype Number of colonies per 2 × 104 cells
Total Blast G GM M Eo E Meg E/Meg Mix
BM +/+ 125 ± 13 9 ± 2 37 ± 2 34 ± 13 21 ± 1 2 ± 1 5 ± 6 12 ± 6 4 ± 2 1 ± 2
+/– 102 ± 30 6 ± 4 36 ± 17 23 ± 3 11 ± 3 2 ± 1 6 ± 6 9 ± 7 8 ± 3 1 ± 2
–/– 78 ± 23* 5 ± 3 23 ± 3 22 ± 10 10 ± 3 2 ± 2 5 ± 1 8 ± 2 3 ± 2 1 ± 1
Spleen +/+ 98 ± 6 8 ± 3 27 ± 1 22 ± 4 17 ± 2 2 ± 0 10 ± 1 7 ± 5 7 ± 1 0.7 ± 0.6
+/– 66 ± 12* 3 ± 3 18 ± 3 17 ± 6 16 ± 5 1 ± 2 4 ± 3 3 ± 1 3 ± 5 0.7 ± 0.6
–/– 42 ± 9* 4 ± 3 12 ± 4 9 ± 3 6 ± 2 0.3 ± 0.6 4 ± 1 3 ± 1 4 ± 3 0.5 ± 0.6
Liver +/+ 63 ± 9 6 ± 2 18 ± 5 14 ± 5 16 ± 9 0 3 ± 1 3 ± 4 2 ± 1 0.7 ± 0.6
+/– 74 ± 13 10 ± 2 18 ± 3 15 ± 7 18 ± 3 0.7 ± 0.6 7 ± 5 2 ± 1 3 ± 2 0.7 ± 0.6
–/– 62 ± 13 5 ± 2 19 ± 8 15 ± 2 10 ± 4 0 6 ± 3 5 ± 4 2 ± 1 0.5 ± 0.6
Mean ± standard deviations of colony numbers from neonatal NR6+/+
NR6+/– or NR6–/– bone marrow, spleen or liver. Replicate cultures
(2 × 104 cells) from each mouse were stimulated with 10 ng/ml IL-3,
100 ng/ml SCF and 4 U/ml EPO and incubated for 7 days in a
humidified atmosphere of 5% CO2 in air. Statistical comparisons were
performed using Student’s t-test on total colony data from NR6+/– or
NR6–/– mice versus NR6+/+. *p < 0.05, n = 3 or 4 mice of each
genotype. BM, bone marrow; G, granulocyte; GM, granulocyte-
macrophage; M, macrophage; Eo, eosinophil; E, erythroid; Meg,
megakaryocyte; E/Meg, mixed erythroid/megakaryocyte; Mix, colonies
containing cells of three or more lineages.
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Supplementary materials and methods
cDNA cloning
Mouse testis, brain (Stratagene) and KUSA cell cDNA libraries were
screened with an oligonucleotide complementary to the sequence
encoding the WSXWS motif as previously described [S1]. A total of
18 cDNA clones were obtained which appeared to encode a novel
member of the haemopoietin receptor family, NR6. Murine cDNA
inserts were then used as hybridisation probes under low stringency
conditions to isolate human NR6 cDNAs from foetal liver, foetal kidney
and placental libraries (Stratagene) using standard techniques.
RNA expression analyses
In situ hybridisation analyses were performed on tissues that were fixed
in 4% paraformaldehyde, dehydrated, embedded in paraffin and sec-
tioned. Hybridisation to whole-mount and embryonic sections were per-
formed as described previously [S2,S3], except that embryos and
sections were treated with 20 mg/ml proteinase K (Boehringer
Mannheim). The full length NR6 cDNA was used as probe. Whole
mount in situ hybridisation was performed at 70°C and in situ hybridis-
ation to tissue sections was performed at 50°C.
Generation of NR6-deficient mice
To construct the NR6 targeting vector, 4.1 kb of murine genomic NR6
DNA containing exons 2 through to 6 was deleted and replaced with a
G418-resistance cassette, leaving 5′ and 3′ arms of NR6 homology of
2.9 and 4.5 kb, respectively. The targetting vector was linearised and
electroporated into W9.5 embryonic stem cells. Colonies of cells resis-
tant to 175 µg/ml G418 were picked and expanded after 8 days in
selection medium. Clones in which the targeting vector had recom-
bined with the endogenous NR6 gene were identified by hybridising
SpeI-digested genomic DNA with a 0.6 kb XhoI–StuI genomic NR6
fragment, which distinguished between the endogenous (9.9 kb) and
targeted (7.1 kb) NR6 loci. Homologous recombination at the NR6
locus was observed in 19 of 158 clones analysed (12%). Two targeted
ES cell clones were injected into C57Bl/6 blastocysts to generate
chimeric mice. Male chimaeras were mated with C57Bl/6 females to
yield NR6 heterozygotes, which were subsequently interbred to
produce wild-type (NR6+/+), heterozygous (NR6+/–) and mutant
(NR6–/–) offspring. The genotypes of offspring were determined by
Southern blot analysis of genomic DNA extracted from tail biopsies.
DNA extraction, digestion with restriction endonucleases and process-
ing of Southern blots were performed as described [S4].
Histological and haematological analyses
Neonatal NR6–/– mice were compared histologically with normal litter-
mates using whole animal serial sagittal sections following fixation in
Bouin’s fixative and staining with haematoxylin and eosin (H&E). Mor-
phological studies of the brain were conducted on H&E-stained serial
coronal sections of tissues fixed in 4% paraformaldehyde. Sagittal sec-
tions of the brain, face and mouth of several animals were also exam-
ined. In this experiment, although not in other anatomical studies, the
histology of the brains of the newborn NR6 null mice was slightly infe-
rior to that of the control, possibly due to failure of NR6–/– mice to feed
causing progressive development of metabolic abnormalities. The
clonal culture of haemopoietic progenitor cells was performed in 1 ml
cultures of 104 (foetal liver) or 2 × 104 (neonatal bone marrow, spleen
or liver) cells in 0.3% agar in Iscove’s modified Dulbecco’s medium
(IMDM) supplemented with 20% fetal calf serum (FCS), 10 ng/ml
murine IL-3, 100 ng/ml murine (stem cell factor) SCF and 4 U/ml
human EPO. Parallel cultures were stimulated using 100 ng/ml SCF or
10 ng/ml M-CSF. Agar cultures were fixed and sequentially stained for
acetylcholinesterase, Luxol fast blue and haematoxylin, and the compo-
sition of each colony was determined at 100–400-fold magnifications
as previously described [S5].
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